Jump to contents

Researcher Information

last modified：2024/11/21

Assistant Professor　MAKINO, Tomoyuki

Faculty, Affiliation

Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences

College and School Educational Field


Laboratory

Academic Background

Career

Year & Month of Birth

Academic Society










Award

Specialities

Speciality Keywords

Research Themes

Books

Papers

  • 　Crosstalk Between Androgen-sensitive and Androgen-insensitive Prostate Cancer Cells.　Yuta Takezawa,Kouji Izumi,Kazuaki Machioka,Hiroaki Iwamoto,Renato Naito,Tomoyuki Makino,Suguru Kadomoto,Ariunbold Natsagdorj,Yoshifumi Kadono,Evan T Keller,Jian Zhang,Atsushi Mizokami　Anticancer research　38　4　2045　2018/04
  • 　Significance of Perioperative Chemotherapy in Squamous Cell Carcinoma of the Upper and Lower Urinary Tract.　Tomoyuki Makino,Kouji Izumi,Ariunbold Natsagdorj,Hiroaki Iwamoto,Suguru Kadomoto,Renato Naito,Yoshifumi Kadono,Atsushi Mizokami　Anticancer research　38　4　2241　2018/04
  • 　Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy.　Tomoyuki Makino,Sotaro Miwa,Kiyoshi Koshida　Prostate international　4　4　152　2016/12
  • 　Clinical outcomes of patients with localized and locally advanced prostate cancer undergoing high-dose-rate brachytherapy with external-beam radiotherapy at our institute.　Tomoyuki Makino,Atsushi Mizokami,Mikio Namiki　Anticancer research　35　3　1723　2015/03
  • 　Intrapelvic fat makes robot-assisted radical prostatectomy difficult.　Yoshifumi Kadono,Satoru Ueno,Tomoyuki Makino,Mitsuo Ofude,Kouji Izumi,Toshifimi Gabata,Mikio Namiki　Anticancer research　34　10　5523　2014/10

show all

  • 　Effectiveness and Safety of Pegfilgrastim in BEP Treatment for Patients with Germ Cell Tumor.　Hiroaki Iwamoto,Kouji Izumi,Ariunbold Natsagdorj,Tomoyuki Makino,Takahiro Nohara,Kazuyoshi Shigehara,Yoshifumi Kadono,Atsushi Mizokami　In vivo (Athens, Greece)　32　4　899　2018
  • 　Metastatic Urothelial Carcinoma of the Prepuce and Glans Penis: Suspected Implantation of Non-Muscle-Invasive Bladder Cancer via Urine.　Tomoyuki Makino,Yasuhide Kitagawa,Mikio Namiki　Case reports in oncology　7　2　509　2014/05
  • 　Health-related Quality of Life and Toxicity After Single-fraction High-dose-rate Brachytherapy With External Beam Radiotherapy for Localized and Locally Advanced Prostate Cancer.　Tomoyuki Makino,Kazufumi Nakashima,Masashi Iijima,Shouhei Kawaguchi,Takahiro Nohara,Kazuyoshi Shigehara,Kouji Izumi,Yoshifumi Kadono,Tomoyasu Kumano,Atsushi Mizokami　Anticancer research　39　1　477　2019/01
  • 　Clinical Features and Treatment Outcomes in Patients with Extragonadal Germ Cell Tumors: A Single-center Experience.　Tomoyuki Makino,Hiroyuki Konaka,Mikio Namiki　Anticancer research　36　1　313　2016/01
  • 　Changes in penile length after radical prostatectomy: effect of neoadjuvant androgen deprivation therapy　Kadono, Y.,Nohara, T.,Kawaguchi, S.,Sakamoto, J.,Makino, T.,Nakashima, K.,Iijima, M.,Shigehara, K.,Izumi, K.,Mizokami, A.　Andrology　6　6　2018　
  • 　Mucosa-associated lymphoid tissue lymphoma involving the kidney: a case report and review of the literature.　Tomoyuki Makino,Sotaro Miwa,Kiyoshi Koshida,Atsuhiro Kawashima　International cancer conference journal　5　2　82　2016/04
  • 　Tumor necrosis factor-α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation.　Aerken Maolake,Kouji Izumi,Ariunbold Natsagdorj,Hiroaki Iwamoto,Suguru Kadomoto,Tomoyuki Makino,Renato Naito,Kazuyoshi Shigehara,Yoshifumi Kadono,Kaoru Hiratsuka,Guzailinuer Wufuer,Kent L Nastiuk,Atsushi Mizokami　Cancer science　109　5　1524　2018/05
  • 　Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines.　Kazuaki Machioka,Kouji Izumi,Yoshifumi Kadono,Hiroaki Iwamoto,Renato Naito,Tomoyuki Makino,Suguru Kadomoto,Ariunbold Natsagdorj,Evan T Keller,Jian Zhang,Atsushi Mizokami　Oncotarget　9　22　16185　2018/03/23
  • 　C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment.　Satoko Urata,Kouji Izumi,Kaoru Hiratsuka,Aerken Maolake,Ariunbold Natsagdorj,Kazuyoshi Shigehara,Hiroaki Iwamoto,Suguru Kadomoto,Tomoyuki Makino,Renato Naito,Yoshifumi Kadono,Wen-Jye Lin,Guzailinuer Wufuer,Kazutaka Narimoto,Atsushi Mizokami　Cancer science　109　3　724　2018/03
  • 　The Impact of Hypertension on the Clinicopathological Outcome and Progression of Renal Cell Carcinoma.　Tomoyuki Makino,Kouji Izumi,Hiroaki Iwamoto,Suguru Kadomoto,Renato Naito,Hiroshi Yaegashi,Kazuyoshi Shigehara,Yoshifumi Kadono,Atsushi Mizokami　Anticancer research　40　7　4087　2020/07
  • 　The Efficacy of Second-line Chemotherapy for Advanced or Metastatic Urothelial Cancer.　Renato Naito,Kouji Izumi,Suguru Kadomoto,Tomoyuki Makino,Hiroaki Iwamoto,Hiroshi Yaegashi,Kazuyoshi Shigehara,Yoshifumi Kadono,Atsushi Mizokami　Anticancer research　40　2　1141　2020/02
  • 　Metastatic urachal cancer treated effectively with gemcitabine/cisplatin combination chemotherapy and radiotherapy: A case report.　Hiroshi Yaegashi,Suguru Kadomoto,Renato Naito,Tomoyuki Makino,Hiroaki Iwamoto,Takahiro Nohara,Kazuyoshi Shigehara,Kouji Izumi,Yoshifumi Kadono,Atsushi Mizokami　Molecular and clinical oncology　11　2　139　2019/08
  • 　Initial Experience With Radium-223 Chloride Treatment at the Kanazawa University Hospital.　Kazufumi Nakashima,Tomoyuki Makino,Suguru Kadomoto,Hiroaki Iwamoto,Hiroshi Yaegashi,Masashi Iijima,Shohei Kawaguchi,Takahiro Nohara,Kazuyoshi Shigehara,Kouji Izumi,Yoshifumi Kadono,Shinro Matsuo,Atsushi Mizokami　Anticancer research　39　5　2607　2019/05
  • 　High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma.　Hiroshi Yaegashi,Kouji Izumi,Suguru Kadomoto,Renato Naito,Tomoyuki Makino,Hiroaki Iwamoto,Takahiro Nohara,Kazuyoshi Shigehara,Yoshifumi Kadono,Atsushi Mizokami　Anticancer research　39　1　375　2019/01
  • 　Correction to: Toxicity and clinical outcomes of single‑fraction high‑dose‑rate brachytherapy combined with external beam radiotherapy for high‑/very high‑risk prostate cancer: A dosimetric analysis of toxicity.　Takayuki Sakurai,Shigeyuki Takamatsu,Satoshi Shibata,Koji Iwata,Masashi Taka,Tomoyasu Kumano,Tomoyuki Makino,Atsushi Mizokami,Toshifumi Gabata　Japanese journal of radiology　39　4　404　2021/04
  • 　Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment.　Tomoyuki Makino,Kouji Izumi,Atsushi Mizokami　Biomedicines　9　4　2021/04/12
  • 　The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study.　Tomoyuki Makino,Takayuki Sakurai,Shigeyuki Takamatsu,Hiroaki Iwamoto,Hiroshi Yaegashi,Masashi Iijima,Shohei Kawaguchi,Takahiro Nohara,Kazuyoshi Shigehara,Kouji Izumi,Yoshifumi Kadono,Atsushi Mizokami　International journal of clinical oncology　26　12　2310　2021/12
  • 　Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis.　Suguru Kadomoto,Kouji Izumi,Kaoru Hiratsuka,Taito Nakano,Renato Naito,Tomoyuki Makino,Hiroaki Iwamoto,Hiroshi Yaegashi,Kazuyoshi Shigehara,Yoshifumi Kadono,Hiroki Nakata,Yohei Saito,Kyoko Nakagawa-Goto,Atsushi Mizokami　Cancers　12　1　2019/12/30
  • 　A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells.　Renato Naito,Hiroshi Kano,Takashi Shimada,Tomoyuki Makino,Suguru Kadomoto,Hiroaki Iwamoto,Hiroshi Yaegashi,Kouji Izumi,Yoshifumi Kadono,Hiroki Nakata,Yohei Saito,Masuo Goto,Kyoko Nakagawa-Goto,Atsushi Mizokami　The Prostate　81　5　295　2021/04
  • 　A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age.　Hiroaki Iwamoto,Kouji Izumi,Suguru Kadomoto,Tomoyuki Makino,Renato Naito,Hiroshi Yaegashi,Kazuyoshi Shigehara,Yoshifumi Kadono,Atsushi Mizokami　Asian journal of andrology　23　1　36　2021
  • 　Reply to Comment on "Kadomoto, S. et al. Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis" Cancers 2020 12, 89.　Suguru Kadomoto,Kouji Izumi,Kaoru Hiratsuka,Taito Nakano,Renato Naito,Tomoyuki Makino,Hiroaki Iwamoto,Hiroshi Yaegashi,Kazuyoshi Shigehara,Yoshifumi Kadono,Hiroki Nakata,Yohei Saito,Kyoko Nakagawa-Goto,Atsushi Mizokami　Cancers　12　2　2020/02/04
  • 　CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells.　Ariunbold Natsagdorj,Kouji Izumi,Kaoru Hiratsuka,Kazuaki Machioka,Hiroaki Iwamoto,Renato Naito,Tomoyuki Makino,Suguru Kadomoto,Kazuyoshi Shigehara,Yoshifumi Kadono,Wen-Jye Lin,Aerken Maolake,Atsushi Mizokami　Cancer science　110　1　279　2019/01
  • 　Squamous or Glandular Differentiation Predicts Poor Prognosis in pT1 Urothelial Carcinoma.　Ryunosuke Nakagawa,Hiroaki Iwamoto,Tomoyuki Makino,Suguru Kadomoto,Hiroshi Yaegashi,Kazuyoshi Shigehara,Kouji Izumi,Yoshifumi Kadono,Atsushi Mizokami　In vivo (Athens, Greece)　36　5　2365　2022
  • 　Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells.　Hiroaki Iwamoto,Kouji Izumi,Ariunbold Natsagdorj,Renato Naito,Tomoyuki Makino,Suguru Kadomoto,Kaoru Hiratsuka,Kazuyoshi Shigehara,Yoshifumi Kadono,Kazutaka Narimoto,Yohei Saito,Kyoko Nakagawa-Goto,Atsushi Mizokami　The Prostate　79　5　468　2019/04
  • 　An important step in establishing a treatment strategy for small renal masses of clear cell renal cell carcinoma based on the significance of adverse histopathologic features on tumor needle biopsy.　Suguru Kadomoto,Tomoyuki Makino,Kouji Izumi,Atsushi Mizokami　Annals of translational medicine　7　Suppl 8　S374　2019/12
  • 　Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer.　Tomoyuki Makino,Kouji Izumi,Hiroaki Iwamoto,Atsushi Mizokami　Cancers　13　17　2021/09/05
  • 　Androgen receptor signaling-targeted therapy and taxane chemotherapy induce visceral metastasis in castration-resistant prostate cancer.　Hiroaki Iwamoto,Kouji Izumi,Takashi Shimada,Hiroshi Kano,Suguru Kadomoto,Tomoyuki Makino,Renato Naito,Hiroshi Yaegashi,Kazuyoshi Shigehara,Yoshifumi Kadono,Atsushi Mizokami　The Prostate　81　1　72　2021/01
  • 　Analysis of the Safety of Pegfilgrastim Addition in Bleomycin, Etoposide, and Cisplatin Treatment Patients With Germ Cell Tumors.　Ryunosuke Nakagawa,Hiroaki Iwamoto,Tomoyuki Makino,Suguru Kadomoto,Hiroshi Yaegashi,Masashi Iijima,Shohei Kawaguchi,Takahiro Nohara,Kazuyoshi Shigehara,Kouji Izumi,Yoshifumi Kadono,Atsushi Mizokami　Frontiers in oncology　11　770067　2021
  • 　Poor Prognosis With Intravesical Bacillus Calmette-Guérin History After Photodynamic Diagnosis-assisted Transurethral Resection Using 5-Aminolevulinic Acid.　Tomoyuki Makino,Mitsuo Ofude,Tetsuya Kawahara,Tomohiro Hori,Satoko Urata,Tohru Miyagi　In vivo (Athens, Greece)　36　6　2952　2022
  • 　Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cells.　Tomoyuki Makino,Kouji Izumi,Kaoru Hiratsuka,Hiroshi Kano,Takashi Shimada,Taito Nakano,Suguru Kadomoto,Renato Naito,Hiroaki Iwamoto,Hiroshi Yaegashi,Kazuyoshi Shigehara,Yoshifumi Kadono,Hiroki Nakata,Yohei Saito,Kyoko Nakagawa-Goto,Norihiko Sakai,Yasunori Iwata,Takashi Wada,Atsushi Mizokami　Scientific reports　11　1　675　2021/01/12
  • 　Effectiveness of Vintage Hormone Therapy as Alternative Androgen Deprivation Therapy for Non-metastatic Castration-resistant Prostate Cancer.　Hiroaki Iwamoto,Hiroshi Kano,Takafumi Shimada,Renato Naito,Tomoyuki Makino,Suguru Kadamoto,Hiroshi Yaegashi,Kazuyoshi Shigehara,Kouji Izumi,Yoshifumi Kadonoa,Atsushi Mizokami　In vivo (Athens, Greece)　35　2　1247　2021
  • 　Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy.　Hiroaki Iwamoto,Hiroshi Kano,Takafumi Shimada,Renato Naito,Tomoyuki Makino,Suguru Kadomoto,Hiroshi Yaegashi,Kazuyoshi Shigehara,Kouji Izumi,Yoshifumi Kadono,Atsushi Mizokami　In vivo (Athens, Greece)　35　3　1703　2021
  • 　Examination of Necessity for Pelvic Drain Placement After Robot-assisted Radical Prostatectomy.　Hiroaki Iwamoto,Yoshifumi Kadono,Ryunosuke Nakagawa,Tomoyuki Makino,Suguru Kadomoto,Hiroshi Yaegashi,Masashi Iijima,Shohei Kawaguchi,Takahiro Nohara,Kazuyoshi Shigehara,Kouji Izumi,Atsushi Mizokami　In vivo (Athens, Greece)　35　5　2895　2021
  • 　Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity.　Takayuki Sakurai,Shigeyuki Takamatsu,Satoshi Shibata,Koji Iwata,Masashi Taka,Toshifumi Gabata,Tomoyasu Kumano,Tomoyuki Makino,Atsushi Mizokami　Japanese journal of radiology　38　12　1197　2020/12
  • 　Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience.　Hiroshi Yaegashi,Takahiro Nohara,Kazuyoshi Shigehara,Kouji Izumi,Yoshifumi Kadono,Tomoyuki Makino,Kaname Yamashita,Koushiro Ohtsubo,Hiroko Ikeda,Atsushi Mizokami　Cancer diagnosis & prognosis　2　3　352　2022
  • 　Sarcopenia Is Associated With Aggressive Clinicopathological Outcomes and Is a Poor Prognostic Indicator for Non-metastatic Renal Cell Carcinoma.　Tomoyuki Makino,Kouji Izumi,Hiroaki Iwamoto,Suguru Kadomoto,Yoshifumi Kadono,Atsushi Mizokami　In vivo (Athens, Greece)　37　3　1304　2023
  • 　Effectiveness of Double-J Metallic Mesh Ureteral Stents for Malignant Ureteral Obstruction: A Retrospective Study.　Tomohiro Hori,Tomoyuki Makino,Tetsuya Kawahara,Satoko Urata,Tohru Miyagi　In vivo (Athens, Greece)　37　2　806　2023
  • 　Does the quality of endoscopic equipment influence the recurrence rate after photodynamic diagnosis-assisted transurethral resection of bladder tumor?　Ryunosuke Nakagawa,Takahiro Nohara,Hiroshi Kano,Tomoyuki Makino,Renato Naito,Hiroaki Iwamoto,Hiroshi Yaegashi,Shohei Kawaguchi,Kazuyoshi Shigehara,Kouji Izumi,Atsushi Mizokami　Photodiagnosis and photodynamic therapy　46　104023　2024/02/22
  • 　Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer.　Hiroaki Iwamoto,Kouji Izumi,Tomoyuki Makino,Atsushi Mizokami　Cancers　14　7　2022/04/01
  • 　Favorable Impact on Postoperative Abdominal Symptoms in Robot-assisted Radical Prostatectomy Using Enhanced Recovery After Surgery Protocol.　Tomohiro Hori,Tomoyuki Makino,Rikushi Fujimura,Atsuya Takimoto,Satoko Urata,Tohru Miyagi　Cancer diagnosis & prognosis　2　2　247　2022
  • 　Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer.　Hiroaki Iwamoto,Kouji Izumi,Ryunosuke Nakagawa,Ren Toriumi,Shuhei Aoyama,Taiki Kamijima,Takafumi Shimada,Hiroshi Kano,Tomoyuki Makino,Renato Naito,Suguru Kadomoto,Hiroshi Yaegashi,Shohei Kawaguchi,Takahiro Nohara,Kazuyoshi Shigehara,Yoshifumi Kadono,Atsushi Mizokami　Biomedicines　10　10　2022/09/22
  • 　Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men.　Ryunosuke Nakagawa,Hiroaki Iwamoto,Tomoyuki Makino,Renato Naito,Suguru Kadomoto,Norihito Akatani,Hiroshi Yaegashi,Shohei Kawaguchi,Takahiro Nohara,Kazuyoshi Shigehara,Kouji Izumi,Yoshifumi Kadono,Atsushi Takamatsu,Kotaro Yoshida,Atsushi Mizokami　Cancers　14　19　2022/10/02
  • 　Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer.　Takafumi Shimada,Kouji Izumi,Hiroshi Kano,Suguru Kadomoto,Tomoyuki Makino,Renato Naito,Hiroaki Iwamoto,Hiroshi Yaegashi,Yoshifumi Kadono,Atsushi Mizokami　Anticancer research　42　2　1065　2022/02
  • 　Procalcitonin in advanced urological cancer-bacterial versus non-bacterial infections: prospective cohort study.　Hiroshi Yaegashi,Kouji Izumi,Ren Toriumi,Shuhei Aoyama,Taiki Kamijima,Hiroshi Kano,Tomoyuki Makino,Renato Naito,Hiroaki Iwamoto,Shohei Kawaguchi,Takahiro Nohara,Kazuyoshi Shigehara,Atsushi Mizokami　BMJ supportive & palliative care　2024/02/23
  • 　Treatment Outcomes in Neuroendocrine Prostate Cancer.　Hiroaki Iwamoto,Ryunosuke Nakagawa,Tomoyuki Makino,Suguru Kadomoto,Hiroshi Yaegashi,Takahiro Nohara,Kazuyoshi Shigehara,Kouji Izumi,Yoshifumi Kadono,Atsushi Mizokami　Anticancer research　42　4　2167　2022/04
  • 　Does radical cystectomy have a better prognosis than bladder conservative treatment in the real world?　Ryunosuke Nakagawa,Kouji Izumi,Ren Toriumi,Shuhei Aoyama,Taiki Kamijima,Tomoyuki Makino,Renato Naito,Hiroaki Iwamoto,Hiroshi Yaegashi,Shohei Kawaguchi,Kazuyoshi Shigehara,Takahiro Nohara,Atsushi Mizokami　International Journal of Urology　31　6　628　2024/02/15
  • 　Factors Affecting Prostate Displacement During Volumetric Modulated Arc Therapy in Prone Position After High-Dose-Rate Brachytherapy for Prostate Cancer.　Takayuki Sakurai,Shigeyuki Takamatsu,Satoshi Shibata,Risako Minamikawa,Masahiro Yamazaki,Hironori Kojima,Kimiya Noto,Tomoyuki Makino,Shohei Kawaguchi,Takahiro Nohara,Atsushi Mizokami,Toshifumi Gabata　Advances in radiation oncology　8　6　101277　2023
  • 　Epidemiology and Prevention of Renal Cell Carcinoma.　Tomoyuki Makino,Suguru Kadomoto,Kouji Izumi,Atsushi Mizokami　Cancers　14　16　2022/08/22
  • 　Salvage Androgen Deprivation Therapy as Potential Treatment for Recurrence after Robot-Assisted Radical Prostatectomy　hiroshi knao,Yoshifumi Kadono,Renato Naito,Tomoyuki Makino,hiroaki iwamoto,Hiroshi Yaegashi,Shohei Kawaguchi,Takahiro Nohara,Kazuyoshi Shigehara,Kouji Izumi,Atsushi Mizokami　Cancers　16　7　2024/03/27　
  • 　Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma.　Tomoyuki Makino,Kouji Izumi,Hiroaki Iwamoto,Suguru Kadomoto,Yoshifumi Kadono,Atsushi Mizokami　Biomedicines　11　2　2023/02/12
  • 　Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate Cancer　hiroshi knao,Kouji Izumi,Ryunosuke Nakagawa,Ren Toriumi,Shuhei Aoyama,Taiki Kamijima,Tomoyuki Makino,Renato Naito,hiroaki iwamoto,Hiroshi Yaegashi,Shohei Kawaguchi,Kazuyoshi Shigehara,Takahiro Nohara,Atsushi Mizokami　Biomedicines　12　2　2024/01/26　
  • 　Comparison of postoperative urinary continence and incontinence types between conventional and Retzius-sparing robot-assisted radical prostatectomy.　Yoshifumi Kadono,Takahiro Nohara,Shohei Kawaguchi,Tomoyuki Makino,Renato Naito,Suguru Kadomoto,Hiroaki Iwamoto,Hiroshi Yaegashi,Kazuyoshi Shigehara,Kouji Izumi,Atsushi Mizokami　Neurourology and urodynamics　42　6　1411　2023/08
  • 　Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma.　Tomoyuki Makino,Kouji Izumi,Hiroaki Iwamoto,Suguru Kadomoto,Atsushi Mizokami　Biomedicines　11　6　2023/06/01
  • 　Usefulness of serum CCL2 as prognostic biomarker in prostate cancer: a long-term follow-up study.　Hiroaki Iwamoto,Kouji Izumi,Ryunosuke Nakagawa,Ren Toriumi,Shuhei Aoyama,Takafumi Shimada,Hiroshi Kano,Tomoyuki Makino,Suguru Kadomoto,Hiroshi Yaegashi,Shohei Kawaguchi,Takahiro Nohara,Kazuyoshi Shigehara,Yoshifumi Kadono,Atsushi Mizokami　Japanese journal of clinical oncology　52　11　1337　2022/11/03

Conference Presentations

Others

Arts and Fieldwork

Patent

Theme to the desired joint research

Grant-in-Aid for Scientific Research

○「ドラッグリポジショニングによる分子標的薬耐性腎細胞癌に対する克服薬の探索」(2024-2025)　

Competitive research funding,Contribution

Collaborative research,Consignment study

Classes (Bachelors)

Classes (Graduate Schools)

International Project

International Students

Lecture themes

Others (Social Activities)

To Page Top